Log in to your Inderes Free account to see all free content on this page.
Zealand Pharma
729.5
DKK
-0.07 %
ZEAL
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
18 following
-0.07%
-13.1%
-17.2%
+11.63%
+95.47%
+120.93%
+442.78%
+257.95%
+817.61%
www.zealandpharma.com
Zealand Pharma is a biotechnology company. Particular focus is found in the development of drugs for the treatment of diabetes and various intestinal diseases. The company has a varied product portfolio with separate brands that are sold on a global level. The largest business is in the Nordic market. Zealand Pharma was founded in 1997 and is headquartered in Söborg, Denmark.
Revenue
342.79M
EBIT %
-166.94 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Copenhagen
ZEAL
Daily low / high price
727.5 / 735.5
DKK
Market cap
51.81B DKK
Turnover
6.58M DKK
Volume
9K
Financial calendar
Annual report
20.02.2025
Interim report
08.05.2025
Interim report
14.08.2025
Interim report
06.11.2025
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Van Herk Investments | 16.8 % | 16.8 % |
| Credit Suisse Group AG | 6.2 % | 6.2 % |
ShowingAll content types
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Zealand Pharma Announces Financial Results for the First Nine Months of 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio